Gamida Cell (NASDAQ:GMDA) Earns Market Perform Rating from JMP Securities

Gamida Cell (NASDAQ:GMDA – Get Free Report)‘s stock had its “market perform” rating restated by equities research analysts at JMP Securities in a research report issued on Monday, Benzinga reports. A number of other research analysts have also recently commented on GMDA. Piper Sandler dropped their target price on shares of Gamida Cell from $5.00 […]

Related Keywords

United States ,America ,Piper Sandler ,America Corp ,Hermes Inc ,Needham Company ,Jpmorgan Chase Co ,Gamida Cell Ltd ,Gamida Cell ,Get Free Report ,Cell Ltd ,Gamida Cell Daily ,Nasdaq Gmda ,Gmda ,Medical ,Reiterated Rating ,Jmp Securities ,